© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock surged +11.48%, trading at $0.98 on NASDAQ, up from the previous close of $0.88. The stock opened at $0.91, fluctuating between $0.86 and $1.01 in the recent session.
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Employees | 8 |
Beta | 0.74 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) stock price is $0.98 in the last trading session. During the trading session, SHPH stock reached the peak price of $1.01 while $0.86 was the lowest point it dropped to. The percentage change in SHPH stock occurred in the recent session was 11.48% while the dollar amount for the price change in SHPH stock was $0.10.
The NASDAQ listed SHPH is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Shuttle Pharmaceuticals Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Anatoly Dritschilo M.D.
Co-Founder, MD, Chief Executive Officer & Chairman
Mr. Michael P. Vander Hoek
Chief Financial Officer and Vice President of Operations & Regulatory
Dr. Mira Jung Ph.D.
Co-Founder & Chief Scientific Officer for Biology
Dr. Tyvin A. Rich M.D.
Chief Medical Officer
Mr. Peter Dale Dritschilo M.B.A., M.D.
Pres & Chief Operating Officer
Mr. Gene Jung Esq.
Gen. Counsel
Dr. Milton Brown CSC, M.D., Ph.D.
Co-Founder & Director
Dr. Theodore L. Phillips M.D., Ph.D.
Clinical Director
Mr. Michael Jeffrey Starkweather
Vice President of Bus. Devel.
SHPH's closing price is 69.14% higher than its 52-week low of $0.58 where as its distance from 52-week high of $4.71 is -79.18%.
Number of SHPH employees currently stands at 8.
Official Website of SHPH is: https://www.shuttlepharma.com
SHPH could be contacted at phone 240 403 4212 and can also be accessed through its website. SHPH operates from One Research Court, Rockville, MD 20850, United States.
SHPH stock volume for the day was 514.3K shares. The average number of SHPH shares traded daily for last 3 months was 1.18M.
The market value of SHPH currently stands at $4.00M with its latest stock price at $0.98 and 4.08M of its shares outstanding.